- ANNOUNCEMENT -
An updated Letter of Agreement will be implemented for US Accredited Activities on September 1, 2021.
CLICK HERE to view the new template.
Jazz Pharmaceuticals (JAZZ) is committed to improving patient outcomes and providing support in compliance with local regulations.
This system is currently accepting requests for medical education meetings, conferences, or symposia; medical center grand rounds lectures; fellowships; enduring medical education activities; and similar educational activities. In Europe and Rest of World (EU/RoW) the system is also accepting requests for goods (such as books, printing, materials, equipment) and services (such as administrative support, personnel, and tools).
Link to the 2023 Provider Questionnaire for organizations interested in presenting educational concepts to the team as part of our annual planning process.
For additional information regarding this process please email mededgrant@jazzpharma.com.
Requests for Applications (RFAs): (1) Importance of asparagine complete depletion using asparaginase in the treatment of acute lymphoblastic leukemia
(2) Prevalence, Diagnosis, Treatment, and Burden of Illness of EDS in OSA
(3) Diagnosis, Treatment, and Burden of Illness of Idiopathic Hypersomnia
(4) Narcolepsy Burden of Illness, Cardiovascular Health, Treatment, and Diagnosis
Eligible educational grant applicants include the following (not an exhaustive list):
- Medical Schools
- Medical Associations/Medical Societies
- Hospitals/Medical Centers
- Medical Education Providers
All decisions regarding support are at the discretion of JAZZ and will be communicated by email.
Submission of a request does not guarantee support.
For any grant related inquiries please email us at mededgrant@jazzpharma.com.